These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21464051)

  • 1. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.
    Patti G; Cannon CP; Murphy SA; Mega S; Pasceri V; Briguori C; Colombo A; Yun KH; Jeong MH; Kim JS; Choi D; Bozbas H; Kinoshita M; Fukuda K; Jia XW; Hara H; Cay S; Di Sciascio G
    Circulation; 2011 Apr; 123(15):1622-32. PubMed ID: 21464051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
    PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
    Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis.
    Zhai C; Cong H; Liu Y; Zhang Y; Liu X; Zhang H; Ren Z
    Clin Cardiol; 2015 Nov; 38(11):668-78. PubMed ID: 26442621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials.
    Liu J; Zhang B; Chen M; Zheng B
    Medicine (Baltimore); 2021 Jun; 100(25):e26278. PubMed ID: 34160392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis.
    Merla R; Reddy NK; Wang FW; Uretsky BF; Barbagelata A; Birnbaum Y
    Am J Cardiol; 2007 Sep; 100(5):770-6. PubMed ID: 17719318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials.
    Mega S; Patti G; Cannon CP; Di Sciascio G
    Crit Pathw Cardiol; 2010 Mar; 9(1):19-22. PubMed ID: 20215906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction.
    Norris DM; Anderson JR
    Cardiol Rev; 2012; 20(6):319-24. PubMed ID: 22874885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury.
    Mulukutla SR; Marroquin OC; Smith C; Varghese R; Anderson WD; Lee JS; Cohen HA; Counihan PJ; Lee AB; Gulati V; McNamara D
    Am J Cardiol; 2004 Dec; 94(11):1363-6. PubMed ID: 15566904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
    Pascual DA; Arribas JM; Tornel PL; Marín F; Oliver C; Ahumada M; Gomez-Plana J; Martínez P; Arcas R; Valdes M
    Ann Thorac Surg; 2006 Jan; 81(1):78-83. PubMed ID: 16368340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuative statin therapy after percutaneous coronary intervention improves outcome in coronary bypass surgery: a propensity score analysis of 2501 patients.
    Mannacio V; Meier P; Antignano A; Mottola M; Di Tommaso L; Musumeci F; Vosa C
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1876-83. PubMed ID: 24667027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.
    Winchester DE; Wen X; Xie L; Bavry AA
    J Am Coll Cardiol; 2010 Sep; 56(14):1099-109. PubMed ID: 20825761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.